CRISPR/Cas活動のプログラム可能な制御のためのトポロジー・エンジニアリングされたガイドRNA
Liang Cheng1,2
1Beijing National Laboratory for Molecular Sciences (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
Angewandte Chemie (International ed. in English)
|September 4, 2025
まとめ
トポロジー・エンジニアリングされたガイドRNA (TE-gRNA) は,CRISPR遺伝子編集を精密に制御します. これらの高度なRNA構造は,条件付きおよび可逆の編集を可能にし,強化されたアプリケーションのための伝統的な方法の限界を克服します.
科学分野:
- 分子生物学
- バイオテクノロジー
- 化学工学
背景:
- CRISPR/Casシステムは 強力なゲノム編集機能を備えています
- CRISPRの正確な時間と条件の制御を 達成することは依然として大きな課題です
- 伝統的な線形ガイドRNA (gRNA) は,制御,効率,および可逆性において制限があります.
研究 の 目的:
- トポロジーエンジニアリングによるガイドRNA (TE-gRNA) を制御されたCRISPR/Casゲノム編集のための高度なソリューションとして導入し,レビューする.
- TE-gRNAの構造的多様性と機能的優位性を強調する.
- 様々な生物学的および治療的応用における TE-gRNA の可能性について議論する.
主な方法:
- エンジニアリングはgRNAのRNAトポロジー (ポリマー型,円形型,デンドリマー型) を定義した.
- 外部トリガー制御 (例えば,光,化学信号) の刺激反応リンクやグループを組み込む.
- TE-gRNAの合成,安定性,標的外効果の減少,正確な空間時間的な制御を評価する.
主要な成果:
- TE-gRNAは,CRISPR/Casの活動に対する正確な空間的および時間的な制御を可能にします.
- 定義されたトポロジーは,可逆でプログラム可能な編集の有効化/無効化を可能にします.
- エンジニアリングされた構造は合成の可行性と安定性を高め,オフターゲット効果を軽減します.
結論:
- TE-gRNAは,ダイナミックで条件付きのゲノム編集の達成における重要な進歩を表しています.
- 独特の構造特性により CRISPR システムに対する前例のない制御が可能です
- TE-gRNAは合成生物学,機能的ゲノミクス,治療介入の幅広い可能性を秘めています.
関連する概念動画
CRISPR
52.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.8K
CRISPR/Cas9 Genome Editing
208
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
208
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K


